OAK RIDGE INVESTMENTS LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 184 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2016. The put-call ratio across all filers is 1.20 and the average weighting 0.3%.

Quarter-by-quarter ownership
OAK RIDGE INVESTMENTS LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$6,745,000
+9.1%
148,913
-8.3%
0.50%
+6.5%
Q3 2019$6,180,000
-16.4%
162,323
-4.5%
0.46%
-9.0%
Q2 2019$7,390,000
+7.5%
169,926
-5.9%
0.51%
+16.9%
Q1 2019$6,874,000
-15.6%
180,620
-4.6%
0.44%
-25.4%
Q4 2018$8,143,000
-17.9%
189,283
-6.2%
0.59%
+6.9%
Q3 2018$9,919,000
+41.2%
201,808
-7.9%
0.55%
+37.7%
Q2 2018$7,026,000
+0.8%
219,220
-2.1%
0.40%
+2.8%
Q1 2018$6,973,000
-47.1%
223,868
-22.5%
0.39%
-38.5%
Q4 2017$13,188,000
-2.2%
288,887
-19.5%
0.63%
+14.8%
Q3 2017$13,483,000
-40.4%
359,058
-24.3%
0.55%
-24.1%
Q2 2017$22,625,000
+2.4%
474,309
-2.1%
0.72%
-2.7%
Q1 2017$22,095,000
+27.9%
484,538
-9.4%
0.74%
+32.5%
Q4 2016$17,278,000
-30.1%
534,924
-25.9%
0.56%
-12.6%
Q3 2016$24,705,000
+0.4%
721,934
-1.0%
0.64%
+1.4%
Q2 2016$24,606,000
-70.1%
729,493
-53.0%
0.63%
-40.2%
Q1 2016$82,196,000
+37.7%
1,551,456
+99.6%
1.06%
-26.2%
Q4 2015$59,697,000
+84.0%
777,411
-1.5%
1.43%
+85.0%
Q3 2015$32,437,000
+2.9%
789,227
+77.0%
0.77%
+15.5%
Q2 2015$31,532,000445,8610.67%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Gagnon Advisors, LLC 251,140$19,167,0008.83%
GAGNON SECURITIES LLC 610,933$46,626,0007.60%
Tamarack Advisers, LP 205,000$15,646,0007.40%
Spyglass Capital Management LLC 1,871,040$142,798,0004.88%
Lisanti Capital Growth, LLC 302,413$23,080,0002.59%
Rock Springs Capital Management LP 1,000,000$76,320,0001.92%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 208,197$15,890,0001.76%
JABODON PT CO 49,052$3,744,0001.70%
Zweig-DiMenna Associates LLC 166,675$12,721,0001.70%
NEUMEIER POMA INVESTMENT COUNSEL LLC 317,425$24,226,0001.63%
View complete list of PACIRA PHARMACEUTICALS INC shareholders